However, the diagnosis of an IDH-mutant oligodendroglioma can be made as well without 1p/19q testing if immunohistochemical analyses reveal clear loss of ATRX expression and/or diffuse expression of TP53 [24]. This evidence concerns the gene IDH1 and oligodendroglioma.